These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 17026487

  • 1. Inhaled insulin delivery--where are we now?
    Muchmore DB, Gates JR.
    Diabetes Obes Metab; 2006 Nov; 8(6):634-42. PubMed ID: 17026487
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. New ways of insulin delivery.
    Heinemann L.
    Int J Clin Pract Suppl; 2010 Feb; (166):29-40. PubMed ID: 20377662
    [Abstract] [Full Text] [Related]

  • 5. Unlocking the opportunity of tight glycaemic control. Inhaled insulin: safety.
    Brain JD.
    Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S14-8. PubMed ID: 16135134
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of patients with diabetes mellitus by means of inhaled insulin].
    Simsek S, de Galan BE, Tack CJ, Heine RJ.
    Ned Tijdschr Geneeskd; 2006 Apr 15; 150(15):829-32. PubMed ID: 16676511
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Unlocking the opportunity of tight glycaemic control. Inhaled insulin: clinical efficacy.
    Scherbaum WA.
    Diabetes Obes Metab; 2005 Nov 15; 7 Suppl 1():S9-13. PubMed ID: 16135137
    [Abstract] [Full Text] [Related]

  • 9. Clinical evaluation of inhaled insulin.
    Mastrandrea LD, Quattrin T.
    Adv Drug Deliv Rev; 2006 Oct 31; 58(9-10):1061-75. PubMed ID: 17070613
    [Abstract] [Full Text] [Related]

  • 10. Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study.
    Valensi P, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Wenying Y, IMPROVE Study Group Expert Panel.
    Int J Clin Pract; 2009 Mar 31; 63(3):522-31. PubMed ID: 19187170
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of inhaled insulin (AERx iDMS) compared with subcutaneous insulin therapy in patients with Type 1 diabetes: 1-year data from a randomized, parallel group trial.
    Moses RG, Bartley P, Lunt H, O'Brien RC, Donnelly T, Gall MA, Vesterager A, Wollmer P, Roberts A.
    Diabet Med; 2009 Mar 31; 26(3):260-7. PubMed ID: 19317821
    [Abstract] [Full Text] [Related]

  • 12. Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: a randomized trial.
    Raskin P, Heller S, Honka M, Chang PC, Boss AH, Richardson PC, Amin N.
    Diabetes Obes Metab; 2012 Feb 31; 14(2):163-73. PubMed ID: 21951325
    [Abstract] [Full Text] [Related]

  • 13. Noninjectable methods of insulin administration.
    Cernea S, Raz I.
    Timely Top Med Cardiovasc Dis; 2006 Nov 01; 10():E29. PubMed ID: 17136235
    [Abstract] [Full Text] [Related]

  • 14. Unlocking the opportunity of tight glycaemic control. Promise ahead: the role of inhaled insulin in clinical practice.
    Heine RJ.
    Diabetes Obes Metab; 2005 Nov 01; 7 Suppl 1():S19-23. PubMed ID: 16135135
    [Abstract] [Full Text] [Related]

  • 15. Two-year safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 1 diabetes.
    Skyler JS, Jovanovic L, Klioze S, Reis J, Duggan W, Inhaled Human Insulin Type 1 Diabetes Study Group.
    Diabetes Care; 2007 Mar 01; 30(3):579-85. PubMed ID: 17327324
    [Abstract] [Full Text] [Related]

  • 16. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Ligthelm R, Valensi P, IMPROVE Study Group Expert Panel.
    Curr Med Res Opin; 2009 Nov 01; 25(11):2643-54. PubMed ID: 19751116
    [Abstract] [Full Text] [Related]

  • 17. Inhaled insulin: new technology, new possibilities.
    Bellary S, Barnett AH.
    Int J Clin Pract; 2006 Jun 01; 60(6):728-34. PubMed ID: 16805759
    [Abstract] [Full Text] [Related]

  • 18. Long-term tolerability of inhaled human insulin (Exubera) in patients with poorly controlled type 2 diabetes.
    Barnett AH, Lange P, Dreyer M, Serdarevic-Pehar M, Exubera Phase 3 Study Group.
    Int J Clin Pract; 2007 Oct 01; 61(10):1614-25. PubMed ID: 17877648
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of inhaled human insulin (Exubera) during discontinuation and readministration of therapy in adults with type 1 diabetes: A 3-year randomized controlled trial.
    Skyler JS, Hollander PA, Jovanovic L, Klioze S, Krasner A, Riese RJ, Reis J, Schwartz P, Duggan W, Inhaled Human Insulin Type 1 Diabetes Study Group.
    Diabetes Res Clin Pract; 2008 Nov 01; 82(2):238-46. PubMed ID: 18824271
    [Abstract] [Full Text] [Related]

  • 20. [Perspectives of inhaled insulin treatment].
    Chodorowski Z, Sein Anand J.
    Przegl Lek; 2007 Nov 01; 64(4-5):365-7. PubMed ID: 17724916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.